- Home
- ATXG vs SONN Comparison
ATXG vs SONN Comparison
Compare ATXG & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXG
- SONN
- Stock Information
- Founded
- ATXG 2014
- SONN N/A
- Country
- ATXG China
- SONN United States
- Employees
- ATXG N/A
- SONN N/A
- Industry
- ATXG Professional Services
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- ATXG Consumer Discretionary
- SONN Health Care
- Exchange
- ATXG Nasdaq
- SONN Nasdaq
- Market Cap
- ATXG 4.0M
- SONN 3.8M
- IPO Year
- ATXG N/A
- SONN N/A
- Fundamental
- Price
- ATXG $0.70
- SONN $6.12
- Analyst Decision
- ATXG
- SONN Strong Buy
- Analyst Count
- ATXG 0
- SONN 1
- Target Price
- ATXG N/A
- SONN $20.00
- AVG Volume (30 Days)
- ATXG 2.4M
- SONN 11.3M
- Earning Date
- ATXG 08-13-2025
- SONN 08-13-2025
- Dividend Yield
- ATXG N/A
- SONN N/A
- EPS Growth
- ATXG N/A
- SONN N/A
- EPS
- ATXG N/A
- SONN N/A
- Revenue
- ATXG $4,180,913.00
- SONN $1,000,000.00
- Revenue This Year
- ATXG N/A
- SONN $5,376.22
- Revenue Next Year
- ATXG N/A
- SONN N/A
- P/E Ratio
- ATXG N/A
- SONN N/A
- Revenue Growth
- ATXG N/A
- SONN 978.39
- 52 Week Low
- ATXG $0.49
- SONN $1.08
- 52 Week High
- ATXG $1.86
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- ATXG 57.52
- SONN 65.60
- Support Level
- ATXG $0.62
- SONN $7.63
- Resistance Level
- ATXG $0.74
- SONN $19.30
- Average True Range (ATR)
- ATXG 0.09
- SONN 2.03
- MACD
- ATXG 0.01
- SONN 0.41
- Stochastic Oscillator
- ATXG 35.20
- SONN 32.15
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.